Distal Renal Denervation
Anatomically Optimized Distal Renal Denervation for Treatment of Resistant Hypertension
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences
This NA trial investigates Hypertension, Resistant to Conventional Therapy and is currently completed. Tomsk National Research Medical Center of the Russian Academy of Sciences leads this study, which shows 9 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Nov 2021 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: PHASE1_PHASE2 → NA
-
Dec 2018 — Mar 2019 [monthly]
Unknown Status PHASE1_PHASE2
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tomsk National Research Medical Center of the Russian Academy of Sciences
For direct contact, visit the study record on ClinicalTrials.gov .